Bowel Management Systems Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Bowel Management Systems Market Report is Segmented by Product (Ostomy Bags [Colostomy Bags, and More], Transanal Irrigation Systems, Nerve Modulation Devices, Anal Implants & Artificial Sphincters, and More), Patient Type (Pediatric, Adult, Geriatric), End User (Hospitals, Ambulatory Centers, and More), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Bowel Management Systems Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Bowel Management Systems Market with other markets in Healthcare Industry

Bowel Management Systems Market Analysis by Mordor Intelligence

The Bowel Management Systems Market size is estimated at USD 2.57 billion in 2025, and is expected to reach USD 3.18 billion by 2030, at a CAGR of 4.34% during the forecast period (2025-2030).

The modest but steady trajectory mirrors a confluence of aging populations, rising inflammatory bowel disease (IBD) prevalence, and rapid uptake of smart, sensor-enabled ostomy and neuromodulation solutions. North America retains demand leadership on the back of robust reimbursement and early technology adoption, while Asia-Pacific shows the most dynamic expansion as health-system investments meet sharply climbing IBD incidence. Geriatric patients drive incremental volumes because bowel dysfunction prevalence rises steeply after 65 years. Product innovation is shifting the market from passive ostomy care toward active, digitally monitored interventions, particularly nerve modulation devices. Parallel growth in home-care adoption, underpinned by tele-coaching and remote monitoring platforms, further broadens the bowel management systems market footprint.

Key Report Takeaways

  • By product type, ostomy bags led with 53.87% of bowel management systems market share in 2024, whereas nerve modulation devices are forecast to expand at a 6.57% CAGR through 2030.
  • By patient type, adults (18-64 years) held 63.44% share of the bowel management systems market size in 2024, while the geriatric cohort represents the fastest-growing demographic at 7.33% CAGR through 2030.
  • By end user, hospitals accounted for 46.62% share of the bowel management systems market size in 2024; home-care settings are projected to grow at an 8.11% CAGR between 2025-2030.
  • By geography, North America commanded 38.44% bowel management systems market share in 2024, yet Asia-Pacific is forecast to register a 6.94% CAGR to 2030. 

Segment Analysis

By Product: Innovation Drives Nerve Modulation Growth

The bowel management systems market rests on the core demand for ostomy bags, which captured 53.87% share in 2024. Hospitals, home-health nurses, and supply distributors continue to rely on multi-layer hydrocolloid and silicone barriers that maintain secure adhesion and protect peristomal skin. Up-market offerings now incorporate moisture-vapour transmission layers and antimicrobial coatings, allowing vendors to defend margins in a price-sensitive space. Product lifecycles also lengthen as recyclable resins answer tightening single-use-plastic rules in Europe, supporting incremental revenue retention in the bowel management systems market.

Nerve modulation devices deliver the fastest expansion at a 6.57% CAGR by leveraging sacral, tibial, and spinal pathways to restore bowel continence. Boston Scientific’s USD 3.7 billion purchase of Axonics combined acute implant know-how with global sales reach, fuelling portfolio synergies and intensifying rivalry with Medtronic. The bowel management systems industry’s neuromodulation pipeline now spans battery-free microstimulators and externalized pulse-generator options designed for ambulatory surgery centres. Wellspect’s Navina irrigation kits and magnetic sphincter implants form a vibrant middle tier, offering step-up alternatives to conventional pouches while avoiding permanent diversion.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Patient Type: Geriatric Segment Accelerates

Adults aged 18-64 held 63.44% share of the bowel management systems market size in 2024, reflecting the prevalence of IBD, colorectal cancer resection, and trauma-induced ostomy requirements across the working population. Employer health plans in North America and Europe reimburse premium convex pouches and digital leakage sensors, thereby underpinning steady value growth. Clinics also report rising neuromodulation referrals among younger Crohn’s disease sufferers who experience refractory incontinence, broadening device penetration beyond historically geriatric indications.

The geriatric cohort grows fastest as the global 65+ population expands and multimorbidity elevates constipation and fecal incontinence risk are advancing at 7.33% CAGR. Limited dexterity and cognitive decline spur demand for one-piece closed-end pouches with audible coupling rings, automated stoma-temperature alerts, and tele-nursing support. Smart diaper sensors already cut dermatitis scores by 30% in nursing-home trials. Manufacturers framing user-centric design for elder self-care are well positioned to gain share within the bowel management systems industry.

By End User: Home Care Settings Lead Growth

Hospitals remain the dominant outlet with market share of 46.62% in 2024, with procedure-related initiation and complex implant work delivering predictable volume. Yet the drive for cost-containment and preference for recuperation at home means payers increasingly subscribe to remote monitoring packages. Approximately 725,000-1,000,000 Americans rely on specialised ostomy supplies delivered by the Home Medical Equipment channel. Consequently, home-care represents the fastest-growing distribution node and expands at an 8.11% CAGR, making it a linchpin of future bowel management systems market penetration.

Ambulatory surgery centres benefit from shorter dwell times of next-generation sacral stimulators, moving neuromodulation placement out of main theatre suites. Skilled nursing facilities serve as gatekeepers for frail geriatric patients where on-site ultrasound constipation assessments guide personalised regimens. Digital therapy collaborations such as the Ayble Health–Cleveland Clinic programme illustrate how AI-driven coaching reduces readmissions and improves adherence, broadening clinical confidence in home-centred care pathways across the bowel management systems market.

Bowel Management Systems Market: Market Share by End User
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

North America steers 38.44% of global spending, supported by reimbursement policies that now cover advanced sacral nerve stimulation and high-frequency irrigation systems. ConvaTec attributed 8.2% Continence Care revenue growth to favourable pricing adjustments and an expanding formulary of skin barriers. Payer embrace of digital health monitoring shortens hospital stays and cements the region’s position as an innovation test bed for the bowel management systems market.

Asia-Pacific is the fastest regional climber at a 6.94% CAGR through 2030, driven by rapid epidemiological transition, urbanisation, and public-sector investment in modern surgical suites. Australian clearance of Axonics’ F15 neuromodulator showcases regulators’ receptiveness to cutting-edge interventions. China’s tier-1 hospitals now routinely stock smart pouches, and India’s private insurers pilot bundled payments for transanal irrigation, indicating a pivot from legacy consumables to tech-enabled management across the bowel management systems market.

Europe maintains steady growth anchored by universal healthcare and stringent environmental directives that hasten demand for recyclable pouches. Germany’s permanent reimbursement of a digital IBS therapeutic adds momentum to a broader shift toward software-as-a-medical-device solutions. Meanwhile, Middle East & Africa and South America contribute a rising but still modest share; infrastructure gaps, limited specialist training, and constrained insurance coverage temper near-term adoption despite sizeable untapped patient pools.

Bowel Management Systems Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The bowel management systems market is moderately fragmented, yet recent dealflow signals accelerating consolidation. Boston Scientific’s acquisition of Axonics unites sacral and tibial stimulation technologies under one umbrella, challenging Medtronic’s legacy InterStim platform and reshaping neuromodulation economics. Traditional ostomy stalwarts Coloplast and ConvaTec hedge against commoditisation by rolling out sensor-equipped pouches, recyclable adhesive technology, and multidisciplinary home-care programmes.

Digital health entrants pursue AI-enabled leakage prediction, wound-site imaging, and data-driven adherence coaching to carve out high-growth niches. Patent-filing trends reveal activity in magnetic sphincter designs that offer reversible alternatives to hydraulic cuffs, with several filings detailing rare-earth ring assemblies that reduce erosion risk. Implementation of FDA’s updated Quality Management System Regulation in 2026 is expected to reward well-capitalised manufacturers that can absorb compliance costs, possibly accelerating partnership and licensing deals as smaller players seek scale.

White-space opportunities remain around paediatric-specific hardware, fully biodegradable ostomy components, and closed-loop neuromodulation algorithms that integrate real-time electromyography. Vendors able to pair hardware with reimbursement support and digital therapeutics stand to capture durable share within the bowel management systems market.

Bowel Management Systems Industry Leaders

  1. Becton, Dickinson and Company

  2. ConvaTec Group plc

  3. B Braun SE

  4. Medtronic

  5. Coloplast A/S

  6. *Disclaimer: Major Players sorted in no particular order
Bowel Management Systems Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • May 2025: SafeHeal closed a EUR 35 million Series C round to advance Colovac, an endoluminal bypass sheath positioned as an ostomy-free alternative for colorectal cancer surgery.
  • November 2024: Boston Scientific completed its USD 3.7 billion acquisition of Axonics, adding sacral neuromodulation to its urology and pelvic-health portfolio.
  • September 2024: Axonics received Australia's Therapeutic Goods Administration approval for its sacral neuromodulation device, expanding market access in the Asia-Pacific region.
  • August 2024: FDA approved the Altius Direct Electrical Nerve Stimulation System for chronic phantom limb and residual limb pain in adult amputees, demonstrating expanding applications for neuromodulation technologies.

Table of Contents for Bowel Management Systems Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 High Incidence of Inflammatory Bowel Disease (IBD)
    • 4.2.2 Rapidly Growing Geriatric (65+) Population
    • 4.2.3 Reimbursement Expansion for Ostomy & Neuromodulation Therapies
    • 4.2.4 Smart-Sensor Ostomy Pouches Enabling Remote Monitoring
    • 4.2.5 ESG Push Toward Recyclable Single-Use Ostomy Materials
    • 4.2.6 Tele-Coaching Platforms for Neurogenic Bowel Management
  • 4.3 Market Restraints
    • 4.3.1 Patient Preference for Conservative / Non-Invasive Options
    • 4.3.2 Post-Operative Infections & Device Complication Recalls
    • 4.3.3 High Upfront Cost of Sacral-Nerve Stimulation Implants
    • 4.3.4 Regulatory Scrutiny on Single-Use Plastic Waste
  • 4.4 Porter’s Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitutes
    • 4.4.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value in USD)

  • 5.1 By Product
    • 5.1.1 Ostomy Bags
    • 5.1.1.1 Colostomy Bags
    • 5.1.1.2 Ileostomy Bags
    • 5.1.1.3 Urostomy Bags
    • 5.1.2 Transanal Irrigation Systems
    • 5.1.2.1 Manual Pump-based Irrigation
    • 5.1.2.2 Electronic Smart Irrigation
    • 5.1.3 Nerve Modulation Devices
    • 5.1.3.1 Sacral Nerve Stimulation Systems
    • 5.1.3.2 Tibial Nerve Stimulation Systems
    • 5.1.4 Anal Implants & Artificial Sphincters
    • 5.1.4.1 Hydraulic Artificial Sphincters
    • 5.1.4.2 Magnetic Sphincters
    • 5.1.5 Skin Barriers & Accessories
    • 5.1.5.1 Skin Barrier Sheets & Rings
    • 5.1.5.2 Deodorizing Filters & Pouch Accessories
  • 5.2 By Patient Type
    • 5.2.1 Pediatric (<18 yrs)
    • 5.2.2 Adult (18–64 yrs)
    • 5.2.3 Geriatric (65+ yrs)
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgery Centers
    • 5.3.3 Home Care Settings
    • 5.3.4 Skilled Nursing Facilities
  • 5.4 By Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Coloplast A/S
    • 6.3.2 ConvaTec Group plc
    • 6.3.3 Hollister Incorporated
    • 6.3.4 Medtronic
    • 6.3.5 Becton Dickinson & Company
    • 6.3.6 B. Braun Melsungen AG
    • 6.3.7 3M Company
    • 6.3.8 Boston Scientific Corp.
    • 6.3.9 Wellspect Healthcare
    • 6.3.10 Consure Medical Pvt Ltd
    • 6.3.11 Laborie Medical Technologies
    • 6.3.12 MacGregor Healthcare Ltd
    • 6.3.13 Implantica AG
    • 6.3.14 Cook MyoSite
    • 6.3.15 Abena A/S
    • 6.3.16 Cardinal Health Inc.
    • 6.3.17 Cogentix Medical
    • 6.3.18 Stryker Corp.
    • 6.3.19 Smith & Nephew plc
    • 6.3.20 ABC Medical Supply Inc.

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Bowel Management Systems Market Report Scope

As per the scope of the report, the bowel management system is essentially a soft catheter that is inserted into the rectum to modify the condition of the watery or semi-solid stool and provide remediation. It helps patients with constipation and fecal incontinence and can also be used in spinal cord surgery and other brain disorders. 

The bowel management systems market is segmented by product (colostomy bags, irrigation systems, nerve modulation devices, and other products), patient type (adults and pediatric), end-user (hospitals, ambulatory centers, and other end-users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. 

The report offers the value (in USD million) for the above segments.

By Product Ostomy Bags Colostomy Bags
Ileostomy Bags
Urostomy Bags
Transanal Irrigation Systems Manual Pump-based Irrigation
Electronic Smart Irrigation
Nerve Modulation Devices Sacral Nerve Stimulation Systems
Tibial Nerve Stimulation Systems
Anal Implants & Artificial Sphincters Hydraulic Artificial Sphincters
Magnetic Sphincters
Skin Barriers & Accessories Skin Barrier Sheets & Rings
Deodorizing Filters & Pouch Accessories
By Patient Type Pediatric (<18 yrs)
Adult (18–64 yrs)
Geriatric (65+ yrs)
By End User Hospitals
Ambulatory Surgery Centers
Home Care Settings
Skilled Nursing Facilities
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
By Product
Ostomy Bags Colostomy Bags
Ileostomy Bags
Urostomy Bags
Transanal Irrigation Systems Manual Pump-based Irrigation
Electronic Smart Irrigation
Nerve Modulation Devices Sacral Nerve Stimulation Systems
Tibial Nerve Stimulation Systems
Anal Implants & Artificial Sphincters Hydraulic Artificial Sphincters
Magnetic Sphincters
Skin Barriers & Accessories Skin Barrier Sheets & Rings
Deodorizing Filters & Pouch Accessories
By Patient Type
Pediatric (<18 yrs)
Adult (18–64 yrs)
Geriatric (65+ yrs)
By End User
Hospitals
Ambulatory Surgery Centers
Home Care Settings
Skilled Nursing Facilities
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa GCC
South Africa
Rest of Middle East & Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current size of the bowel management systems market?

The bowel management systems market is valued at USD 2.57 billion in 2025 and is projected to reach USD 3.18 billion by 2030.

Which product segment is growing fastest?

Nerve modulation devices are expanding at a 6.57% CAGR through 2030 as clinical evidence and reimbursement broaden.

Why is Asia-Pacific considered the most attractive growth region?

Rising IBD incidence, major hospital infrastructure investment, and accelerating regulatory approvals give Asia-Pacific the highest regional CAGR at 6.94%.

How are smart-sensor pouches changing ostomy care?

They deliver real-time leakage alerts and remote monitoring, reducing emergency visits and improving user confidence.

What major acquisition has reshaped competitive dynamics?

Boston Scientific’s USD 3.7 billion acquisition of Axonics consolidated sacral neuromodulation technologies and intensified rivalry with Medtronic.

How will forthcoming FDA quality regulations affect the market?

Stricter Quality Management System requirements from 2026 will likely slow small-company approvals but enhance overall device safety and favour well-capitalised manufacturers.

Page last updated on: June 30, 2025

Bowel Management Systems Market Report Snapshots